PRESS RELEASE
Blank Media template
Read time: 2 min

PRESS RELEASE
Read time: 2 min

PRESS RELEASE
January 2016
Read time: 4 min
Schulte Roth & Zabel attorneys have collaborated to update and expand Insider Trading Law and Compliance Answer Book 2016, a book published by Practising Law Institute. This easy-to-use, comprehensive treatise offers an explanation of both the basics and complexities of insider trading law.
Written in a clear, succinct question-and-answer format, this new edition fully integrates recent litigation and regulatory changes — including, importantly, the Second Circuit’s decision in United States v. Newman and its progeny — and provides a step-by-step understanding of the legal requirements imposed upon all investors. Insider Trading Law and Compliance Answer Book 2016 walks readers through the elements of an insider trading claim, what is legitimate company research that can be freely acted upon and what is material, nonpublic information obtained in breach of a duty of trust or confidence that may preclude trading, when acting on a “tip” can incur legal liability, and the framework of civil and criminal penalties when insider trading has been successfully proven. New and expanded topics for the 2016 edition include discussions on the personal benefit requirement for tippee liability, reconsideration of cases in light of Newman, proposed federal insider trading legislation, Bitcoin and other virtual currencies, and training and compliance policies and procedures.
Insider Trading Law and Compliance Answer Book 2016 serves as a reference for investors, corporate insiders, professional traders, investment advisers, broker-dealers and other participants in the securities industry, as well as for the attorneys who advise and represent them. In today’s turbulent financial markets, a claim of insider trading often hits the newspapers, and this timely and practical treatise is a concise road map to help readers safely navigate the major legal regulatory requirements related to insider trading.
Litigation partner Harry S. Davis served as editor and authored several chapters of the book. Additional chapter authors include litigation partners Eric Bensky, Charles J. Clark, Howard O. Godnick, William H. Gussman, Jr., Marcy Ressler Harris, Taleah E. Jennings, David K. Momborquette, Martin L. Perschetz, Howard Schiffman, Gary Stein, Michael E. Swartz, Robert J. Ward and Peter H. White, lawyer Betty Santangelo and special counsel Michael G. Cutini and Jeffrey F. Robertson; business reorganization partner Adam C. Harris; investment management and regulatory & compliance partner Marc E. Elovitz; M&A and securities partners Eleazer Klein and Marc Weingarten; and former Schulte lawyer Alan R. Glickman.
PRESS RELEASE
December 22, 2015
Read time: 4 min
MIAMI (December 22, 2015) — International law firm McDermott Will & Emery acted as legal advisor to private equity firm H.I.G. Capital and trailer manufacturer Big Tex in the sale of the latter to Bain Capital Private Equity. Miami-based partner Harris Siskind, co-head of McDermott’s private equity practice, led the legal team advising on the sale.
Financial terms of the transaction were not disclosed.
In addition to Mr. Siskind, the cross-practice McDermott team representing H.I.G. Capital and Big Tex included Corporate Advisory lawyers Matthew Bielen, Alex Clavero, Cristy Delgado, Gregg Fierman, Gary Rosenbaum and Sarah Steigleder. In addition, McDermott Tax partner Dan Zucker and Employee Benefits partners Maureen O’Brien and Patrick Ryan were members of the deal team.
Headquartered in Mt. Pleasant, Texas, Big Tex manufactures professional grade open utility, equipment, horse, livestock, and cargo trailers and truck beds under such brands as Big Tex, CM, S&H, and Circle J. Founded in 1982, the company serves dealers and customers across North America.
McDermott advised Miami-based H.I.G. Capital with its platform acquisition of Big Tex in 2012 and represented Big Tex on numerous corporate matters throughout HIG Capital’s ownership of the company. Terms of those transactions were not disclosed.
McDermott Will & Emery blends in-depth private equity experience with highly focused industry knowledge—all on a global basis with a best-in-class financing team. McDermott’s private equity practice advises a full range of participants – sponsors, investors, lenders, managers, and portfolio companies – in the private equity market. The firm offers a full-service approach to each deal, including a comprehensive offering of highly ranked and recognized practices, such as corporate, tax, antitrust, regulatory, intellectual property, employment benefits and executive compensation, to address the associated issues that may arise with a private equity transaction.
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.
© 2015 McDermott Will & Emery LLP. McDermott Will & Emery conducts its practice through separate legal entities in each of the countries where it has offices. This communication may be considered attorney advertising. Previous results are not a guarantee of future outcome.

PRESS RELEASE
December 7, 2015
Read time: 3 min
MUNICH (December 7, 2015) – McDermott advised Honeywell on its acquisition of Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.
The acquired business develops and manufactures high-purity research chemicals and other materials used in new drug discovery, medical diagnostic testing and other laboratory applications. The agreement is subject to customary closing conditions, including regulatory review.
The newly acquired business will be integrated into Honeywell’s Fine Chemicals business, which has supplied high-quality research chemicals and specialty organic and inorganic compounds to the chemical and pharmaceutical industries for more than 100 years. Honeywell Fine Chemicals is a part of the Honeywell Performance Materials and Technologies business group, a global leader in developing advanced materials, process technologies and automation solutions.
The McDermott team comprised lawyers from the Firm’s corporate, IP, regulatory, tax, trial and employment practices based in Düsseldorf, Frankfurt, Munich, Dallas and Washington, including partners: Dr. Nikolaus von Jacobs, Carsten Böhm, Jason D. Krieser, Dr. Paul Melot de Beauregard, Sabine Konrad, Dr. Roland Hartmannsberger, Dr. Holger Weiß and Dr. Kian Tauser.
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.

PRESS RELEASE
December 2015
Read time: 3 min
The Hedge Fund Journal recently profiled SRZ’s leading securities litigation practice and spoke to SRZ attorneys about key securities regulatory enforcement and civil litigation issues affecting the private investment fund industry as well as what to expect in 2016. In the article, SRZ partners Eric A. Bensky, Brian T. Daly, Harry S. Davis, William H. Gussman, Jr., David K. Momborquette, Howard Schiffman, Gary Stein and Michael E. Swartz discuss the impact of the seminal Newman decision on insider trading law (including important limitations on the applicability of Newman), collaboration between U.S. and foreign securities regulators, market manipulation cases (including “spoofing” and other actions involving high frequency traders), liability of chief compliance officers and other “gate keepers,” activist investors, antitrust disclosure issues, fines and prime broker liability, compliance with Rule 105 under Regulation M (which relates to short selling in advance of certain secondary offerings), civil litigation relating to appraisal statutes, and the increasing interrelationship between SEC examinations, regulatory investigations and enforcement actions, among other topics.
Click here to read the article.

PRESS RELEASE
Read time: 2 min
PRESS RELEASE
October 15, 2015
Read time: 2 min
This press release is only available in German; click here to read the release in German.

PRESS RELEASE
October 5, 2015
Read time: 2 min
This press release is only available in German; click here to read the release in German.

PRESS RELEASE
October 2015
Read time: 3 min
SRZ partners Robert M. Abrahams, Harry S. Davis, Robert S. Nash and Robert J. Ward have authored three chapters in the fourth edition of the critically acclaimed treatise Commercial Litigation in New York State Courts. Robert Abrahams co-authored the “Document Discovery” chapter with Scott Balber from Herbert Smith Freehills LLP, Harry Davis authored the “Provisional Remedies” chapter, and Robert Nash and Robert Ward co-authored the “Commercial Leasing” chapter with the Honorable Orin R. Kitzes of the Queens County Supreme Court, Commercial Division and Mark Mulholland of Ruskin Moscou Faltischek, P.C. SRZ associate Barbara Reid and former associates Stacy Ma and Shauneida DePeiza Saldenha assisted in the preparation of the chapters.
The eight-volume treatise is a step-by-step practice guide that covers every aspect of a commercial case in New York State courts, from the investigation and assessment that take place at inception through pleadings, discovery, motions, trial, appeal and enforcement of judgment.
A joint venture of Thomson Reuters and the New York County Lawyers’ Association, the fourth edition features the work of 182 expert authors, including some of the best commercial litigators in New York. Enhanced with new and expanded chapters, this seminal work has been completely updated, expanded and revised to address pertinent subjects. The authors discuss the interplay between rules of procedures and substantive law, outline strategies for representation of plaintiffs and defendants, and consider ramifications of various actions.
Order a copy of Commercial Litigation in New York State Courts.
PRESS RELEASE
September 4, 2015
Read time: 3 min
NEW YORK (SEPTEMBER 4, 2015) – McDermott Will & Emery represented Gerresheimer AG (GXI.DE), one of the leading partners to the pharma and healthcare industry worldwide, in its acquisition of Centor, a market leader in the US prescription plastic vial retail market for oral drugs.
Gerresheimer reached the agreement with Nemera Development S.A. to acquire 100 percent of the share capital of Centor US Holding Inc.
The all-cash transaction, which closed on September 1, 2015, is valued at $725 million. With the addition of Centor, Gerresheimer extends its footprint in the primary pharmaceutical packaging market for prescription drugs significantly. Centor will be integrated in the Plastics & Devices Division of Gerresheimer.
The cross-departmental McDermott team was led by New York Corporate Advisory partner Thomas Sauermilch and included:
McDermott Will & Emery is a premier international law firm with a diversified business practice. Numbering more than 1,000 lawyers, we have offices in Boston, Brussels, Chicago, Dallas, Düsseldorf, Frankfurt, Houston, London, Los Angeles, Miami, Milan, Munich, New York, Orange County, Paris, Rome, Seoul, Silicon Valley and Washington, D.C. Further extending our reach into Asia, we have a strategic alliance with MWE China Law Offices in Shanghai.